This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Paul Wrighton, PhD
Senior Scientist II, In Vivo Gene Editing at Editas Medicine
Speaker

Profile

Paul received his PhD from the University of Wisconsin where he investigated the involvement of the extracellular matrix on human pluripotent stem cell differentiation. He completed a postdoctoral fellowship at Brigham and Women’s Hospital and Harvard Medical School, developing in vivo imaging methods to study mitophagy. He began at Editas Medicine in 2021 as a member of the discovery biology team, developing in vivo gene editing medicines targeting the eye and liver.

Agenda Sessions

  • In Vivo CRISPR Editing of Genetic Regulatory Regions Results in Functional Upregulation of Target Protein and Reduction of Disease-Associated Biomarker

    5:15pm